Introduction
============

The most common cause of mortality among patients with diabetes is cardiovascular disease (CVD).[@b1-jcm-4-2013-015] Therefore, CVD prevention has the potential to drastically limit the mortality.[@b2-jcm-4-2013-015] Recent studies have suggested that endothelial function and, specifically, the regulation of vasomotor tone through the release of molecules that mediate vasoconstriction play pivotal roles in the prevention of macrovascular complications in patients with type 2 diabetes.[@b3-jcm-4-2013-015]

Physical activity and exercise promote longevity and ameliorate type 2 diabetes and insulin resistance. Moreover, exercise training can improve endothelial function in patients with diabetes.[@b4-jcm-4-2013-015]--[@b6-jcm-4-2013-015] These results suggest that the improvement of endothelial function could be a surrogate therapeutic target for exercise interventions to reduce the development of CVD in patients with type 2 diabetes.

Cigarette smoking is a recognized risk factor for cardiovascular disease and is known to promote the development of endothelial dysfunction.[@b7-jcm-4-2013-015] In other words, the effects of exercise training and smoking exert opposing effects on vascular endothelial function. Therefore, we hypothesized that smoking counteracts the favorable effect of exercise training on endothelial function. To test this hypothesis, we assessed the effects of exercise on endothelial function in type 2 diabetics who have a history of smoking compared to those who have never smoked.

Materials and Methods
=====================

Study subjects and the intervention protocol
--------------------------------------------

In our study, 44 patients with type 2 diabetes (18 women and 26 men aged 61.8 ± 9.2 years), who visited our outpatient department for an exercise prescription and self-management training, were divided into 2 groups: the never-smoking group (n = 27) and the past or current smoking group (smoking group: n = 17). Thirty-four patients had a medical history of hypertension, but none of the subjects had uncontrolled severe systemic hypertension. Hypercholesterolemia was present in 22 patients, and all of the patients were being administered statins at the time of the study. There was no evidence of autonomic cardiac neuropathy in any of the patients. The exclusion criteria included uncontrolled heart failure, severe or unstable angina pectoris, and age \> 80 years. Patients who were not able to appear for check-up visits and patients refusing to provide written consent were also excluded.

A home-based walking program was adopted as the exercise intervention, because this type of program can foster long-term adherence owing to its convenience and flexibility. This program consisted of a 3 month of daily walking exercise (duration, 20--30 min) at home. Adherence of program was confirmed at the time of check-up visit.

Assessment of endothelial function
----------------------------------

Endothelial function examinations were performed at baseline and after 3 months. In this study, endothelial function was as the percentage decrease in post-exercise ankle-brachial pressure index (ABI) relative to the baseline values. This simple exercise test can be a useful surrogate marker of endothelial dysfunction.[@b8-jcm-4-2013-015] In brief, resting ABI was measured using a Doppler flow meter (VaSera, VS-1000, Fukuda denshi, Japan), with the patient in a supine position, according to a standard protocol. ABI was also measured immediately (60 times/min) after 2.5 min of active pedal flexion exercises.

Statistical analysis
--------------------

Data is expressed as means ± standard deviation (SD). To compare the baseline findings of the 2 groups, we used the unpaired *t* test for continuous variables. Analysis of variance with Bonferroni post-hoc test analysis revealed within time differences between the groups. *P* values below 0.05 were considered statistically significant.

Results
=======

All of the enrolled patients completed the study. In the smoking group, 9 participants (53%) had quit smoking and 8 (47%) smoked at the time of the study. The average non-smoking period of patients who quit smoking was 6.4 ± 5.5 years.

During the study period, medical treatment was maintained effectively, and no severe clinical event was recorded. The basic clinical characteristics were presented in [Table 1](#t1-jcm-4-2013-015){ref-type="table"}. The proportion of women in the smoking group was significantly lower than in the never-smoking group. Patients in the smoking group tended to have lower levels of HDL cholesterol than those in the never-smoking group.

After intervention, HDL cholesterol levels increased similarly in both groups (54.8 ± 17.2 mg/dL to 58.8 ± 18.8 mg/dL in the never-smoking group and 46.6 ± 10.6 mg/dL to 52.9 ± 8.4 mg/dL in the smoking group). Hba~1c~ levels decreased more significantly in the never-smoking group compared to the smoking group during this period (9.1% ± 1.6% to 7.2% ± 1.0% and 8.4% ± 1.4% to 7.7% ± 1.4%, respectively; *P* \< 0.05).

The change in the post-exercise ABI, which is an index of endothelial function, is shown in [Figure 1](#f1-jcm-4-2013-015){ref-type="fig"}. There was a greater improvement in the post-exercise ABI in the never-smoking group compared to the smoking group (*P* \< 0.01). In the never-smoking group, the post-exercise ABI improved significantly (8.2 ± 5.2 to 4.2 ± 5.4; *P* \< 0.01). No change was observed in the smoking group (6.0 ± 4.7 to 7.4 ± 4.9; not significant). These results remained unchanged after adjustment for age, gender, duration of diabetes, insulin use, HDL cholesterol level at baseline, and change in HbA~1c~ ([Table 2](#t2-jcm-4-2013-015){ref-type="table"}). In addition, no significant correlation was observed between smoking habits (quitter or continuing smoker, number of cigarettes smoked per day) and the improvement of endothelial function ([Table 3](#t3-jcm-4-2013-015){ref-type="table"}).

Discussion
==========

The present study shows that a home-based walking program can improve the post-exercise ABI, a marker of endothelial function, in never-smoking patients with type 2 diabetes; further, there was no such change in smokers. These results indicate that smoking may counteract the favorable effect of exercise training on endothelial function.

Cigarette smoking is a strong risk factor for CVD and increases overall mortality in patients with diabetes.[@b9-jcm-4-2013-015] The Nurses' Health Study showed that mortality rates among women with diabetes are strongly related to their smoking habits, with current smokers who smoke 35 cigarettes/day having a twofold higher risk than never-smokers.[@b10-jcm-4-2013-015] A prospective trial of smoking cessation showed a reduction in total mortality rate, with a trend towards a reduction in CVD-related deaths.[@b11-jcm-4-2013-015] Our findings support the results of a prior research on the damage induced by cigarette smoke among patients with diabetes and provide new insight into the potential mechanisms by which smoking contributes to CVD.

In our study, even a history of smoking or current smoking of only a few cigarettes has potentially deleterious effects contributing to endothelial dysfunction. Barua et al have shown that light smoking is just as detrimental as heavy smoking with respect to effects on the NO biosynthetic pathway.[@b12-jcm-4-2013-015] Prior and present studies have shown that the endothelial dysfunction induced by smoking may not be reversible. These results highlight the importance of education to target diabetic patients who have not ever smoked.

Our study had several limitations. First, we used the post-exercise ABI for the assessment of endothelial function; this method is acceptable but is not perfect.[@b8-jcm-4-2013-015] Second, we had no information on the dietary regimen of the patients during the study period; we cannot exclude the possibility that smokers also had poor diets, which would have confounded our results. Third, the smoking assessment was based on self-reports and was not verified. Finally, the number of patients was small---only a large-scale clinical trial would be able to provide definitive evidence on this interesting clinical topic.

Conclusions
===========

To summarize, our study shows that smoking counteracts the favorable effects of exercise training on endothelial function in patients with type 2 diabetes. These data may have important implications concerning the damage associated with smoking in patients with diabetes.
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###### 

Patient's characteristics.

  **Variables**                          **Never smoking (n = 27)**   **Smokers (n = 17)**   ***P* value**
  -------------------------------------- ---------------------------- ---------------------- ---------------
  Age (years)                            61 ± 9                       62 ±10                 0.74
  Gender (females, %)                    59                           12                     0.00
  Yers since diagonosis (years)          6 ± 7                        8 ± 10                 0.57
  Oral hypoglycemic medication (%)       52                           65                     0.30
  Insulin use (%)                        52                           47                     0.50
  Statins (%)                            26                           41                     0.23
  BMI                                    27 ± 4                       27 ± 4                 0.80
  Hypertension (%)                       70                           88                     0.16
  Obesity (%)                            67                           59                     0.42
  History of hypercholesterolmia (%)     52                           47                     0.50
  History of myocardial infarction (%)   4                            0                      0.61
  HbA~1c~ (%)                            9.0 ± 1.6                    8.4 ± 1.4              0.14
  Systolic blood pressure (mmHg)         130 ± 14                     134 ± 19               0.47
  Triglycerides (mg/dL)                  122 ± 61                     115 ± 48               0.70
  HDL cholesterol (mg/dL)                55 ± 16                      47 ± 10                0.06
  LDL cholesterol (mg/dLl)               119 ± 35                     105 ± 21               0.16
  Resting ABI                            1.16 ± 0.9                   1.14 ± 0.8             0.24

###### 

Results of multivariate analysis within group.

                                             **F vale**   ***P* value**
  ------------------------------------------ ------------ ---------------
  Time                                       0.36         0.55
  Time × age                                 0.02         0.90
  Time × gender                              0.03         0.86
  Time × duration of diabetes                0.69         0.42
  Time × insulin use                         0.19         0.67
  Time × HDL cholesterol level at baseline   0.52         0.48
  Time × change in HbA~1c~                   3.66         0.07

###### 

Mean change (as percentage from initial) in smoking habits.

                                            **Change from initial (%)**   **95% CI**   ***P* value**
  ----------------------------------------- ----------------------------- ------------ ---------------
  **Quitter or continuing smoker**                                                     
  Quitter                                   2.5 ± 5                       −4.1--9.0    0.41
  Continuing smoker                         0.09 ± 7                                   
  **Number of cigarettes smoked per day**                                              
  \<20                                      0.7 ± 4                       −10--13      0.83
  ≧20                                       −0.3 ± 9                                   
